| Pines Post Acute And Memory Care | |
| 1625 E Main St, Clintonville, Wisconsin 54929 | |
| (715) 823-3135 | |
| Name | Pines Post Acute And Memory Care |
|---|---|
| Location | 1625 E Main St, Clintonville, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 50 |
| Occupancy Rate | 91.2% |
| Medicare ID (CCN) | 525497 |
| Legal Business Name | Cloverleaf Healthcare Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1104242999 |
| Organization Name | CLOVERLEAF HEALTHCARE LLC |
| Doing Business As | THE PINES POST ACUTE AND MEMORY CARE |
| Address | 1625 E Main St, Clintonville, WI 54929 |
| Phone Number | 715-823-3135 |
News Archive
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis.
In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).
International research involving the University of Adelaide has found that the risk of preterm birth could be halved for a specific group of "super high-risk" twin pregnancies.
Reporting for Kaiser Health News, in collaboration with The Washington Post, Lawrence Lindner writes: "The Obama administration's bid to slash funding for training pediatricians at children's hospitals is provoking intense protests from medical educators and lawmakers on both sides of the aisle".
› Verified 3 days ago
| NPI Number | 1649225392 |
| Organization Name | FIVE STAR QUALITY CARE WI LLC |
| Doing Business As | PINE MANOR HEALTH CARE CENTER |
| Address | 1625 E Main St, Village Of Embarrass, Clintonville, WI 54929 |
| Phone Number | 715-823-3135 |
News Archive
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis.
In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).
International research involving the University of Adelaide has found that the risk of preterm birth could be halved for a specific group of "super high-risk" twin pregnancies.
Reporting for Kaiser Health News, in collaboration with The Washington Post, Lawrence Lindner writes: "The Obama administration's bid to slash funding for training pediatricians at children's hospitals is provoking intense protests from medical educators and lawmakers on both sides of the aisle".
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis.
In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).
International research involving the University of Adelaide has found that the risk of preterm birth could be halved for a specific group of "super high-risk" twin pregnancies.
Reporting for Kaiser Health News, in collaboration with The Washington Post, Lawrence Lindner writes: "The Obama administration's bid to slash funding for training pediatricians at children's hospitals is provoking intense protests from medical educators and lawmakers on both sides of the aisle".
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $18437 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.76 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.69 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 23.73 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.28 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.85 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.13 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.88 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.97 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 25.83 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.13 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.54 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 44.32 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.01 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 16.67 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.33 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 68.59 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.74 | 82.93 |
News Archive
Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis.
In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).
International research involving the University of Adelaide has found that the risk of preterm birth could be halved for a specific group of "super high-risk" twin pregnancies.
Reporting for Kaiser Health News, in collaboration with The Washington Post, Lawrence Lindner writes: "The Obama administration's bid to slash funding for training pediatricians at children's hospitals is provoking intense protests from medical educators and lawmakers on both sides of the aisle".
› Verified 3 days ago
Greentree Health And Rehab Ctr Location: 70 Greentree Rd, Clintonville, Wisconsin 54929 Phone: (715) 823-2194 | |
Pines Post Acute And Memory Care Location: 1625 E Main St, Clintonville, Wisconsin 54929 Phone: (715) 823-3135 |